AKR1B10 and metabolic dysfunction-associated steatohepatitis: Interestingly, increased expression of AKR1B10 was observed in NASH patients compared with NAFL, while FABP5 expression was consistently increased as the disease progresses compared with healthy obese patients (Figure 6A,B).